Surface properties of titanium alloys, used for orthopedic and dental applications, are known to affect implant interactions with host tissues. Osteointegration, bone growth and remodeling in the area surrounding the implants can be implemented by specific biomimetic treatments; these allow the preparation of micro/nanostructured titanium surfaces with a thickened oxide layer, doped with calcium and phosphorus ions. We have challenged these experimental titanium alloys with primary human bone marrow stromal cells to compare the osteogenic differentiation outcomes of the cells once they are seeded onto the modified surfaces, thus simulating a prosthetic device-biological interface of clinical relevance.
Methods
A specific anodic spark discharge was the biomimetic treatment of choice, providing experimental titanium disks treated with different alkali etching approaches. The disks, checked by electron microscopy and spectroscopy, were subsequently used as substrates for the proliferation and osteogenic differentiation of human cells. Expression of markers of the osteogenic lineage was assessed by means of qualitative and quantitative PCR, by cytochemistry, immunohistochemistry Western blot and matrix metalloprotease activity analyses.
Results
Metal surfaces were initially less permissive for cell growth. Untreated control substrates were less efficient in sustaining mineralized matrix deposition upon osteogenic induction of the cells. Interestingly, bone sialo protein and matrix metalloprotease 2 levels were enhanced on experimental metals compared to control surfaces, particularly for titanium oxide coatings etched with KOH.
Discussion
As a whole, the KOH-modification of titanium surfaces seems to allow the best osteogenic differentiation of human mesenchymal stromal cells, representing a possible plus for future clinical prosthetic applications.
VercaigneS., WolkeJ.G., NaertI., JansenJ.A.. Bone healing capacity of titanium plasma-sprayed and hydroxylapatite-coated oral implants.Clin Oral Implants Res1998; 9: 261–71.
2.
BrossaF., CigadaA., ChiesaR., ParacchiniL., ConsonniC.. Adhesion properties of plasma sprayed hydroxylapatite coatings for orthopaedic prostheses.Biomed Mater Eng1993; 3: 127–36.
3.
KnabeC., BergerG., GildenhaarR., MeyerJ., HowlettC.R., MarkovicB., ZreiqatH.. Effect of rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins in vitro.J Biomed Mater Res A2004; 69: 145–54.
4.
O'ConnorD.T., ChoiM.G., KwonS.Y., Paul SungK.L.. New in-sight into the mechanism of hip prosthesis loosening: effect of titanium debris size on osteoblast function.J Orthop Res2004; 22: 229–36.
5.
AkisueT., BauerT.W., FarverC.F., MochidaY.. The effect of particle wear debris on NFkappaB activation and pro-inflammatory cytokine release in differentiated THP-1 cells.J Biomed Mater Res2002; 59: 507–15.
6.
MiyanishiK., TrindadeM.C., MaT., GoodmanS.B., SchurmanD.J., SmithR.L.. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles.J Bone Miner Res2003; 18: 1573–83.
7.
RokkumM., ReigstadA., JohanssonC.B.. HA particles can be released from well-fixed HA-coated stems: histopathology of biopsies from 20 hips 2–8 years after implantation.Acta Orthop Scand2002; 73: 298–306.
8.
Schwartz FoH.O., NovaesA.B.Jr., de CastroL.M., RosaA.L., de OliveiraP.T.. In vitro osteogenesis on a microstructured titanium surface with additional submicron-scale topography.Clin Oral Implants Res2007; 18: 333–44.
9.
KokuboT., KimH.M., KawashitaM., NakamuraT.. Process of calcification on artificial materials.Z Kardiol2001; 90(Suppl 3): S86–91.
10.
GiavaresiG., FiniM., ChiesaR.. A novel multiphase anodic spark deposition coating for the improvement of orthopedic implant osseointegration: an experimental study in cortical bone of sheep.J Biomed Mater Res A2008; 85: 1022–31.
11.
YanW.Q., NakamuraT., KawanabeK., NishigochiS., OkaM., KokuboT.. Apatite layer-coated titanium for use as bone bonding implants.Biomaterials1997; 18: 1185–90.
12.
GiordanoC., ChiesaR., SandriniE., CigadaA., GiavaresiG., FiniM., GiardinoR.. Physical and biological characterizations of a novel multiphase anodic spark deposition coating to enhance implant osseointegration.J Mater Sci Mater Med2005; 16: 1221–9.
13.
ChiesaR., GiavaresiG., FiniM.. In vitro and in vivo performance of a novel surface treatment to enhance osseointegration of endosseous implants.Oral Surg Oral Med Oral Pathol Oral Radiol Endod2007; 103: 745–56.
14.
FosterB.L., NocitiF.H., SwansonE.C.. Regulation of cementoblast gene expression by inorganic phosphate in vitro.Calcif Tissue Int2006; 78: 103–12.
15.
KnabeC., HowlettC.R., KlarF., ZreiqatH.. The effect of different titanium and hydroxyapatite-coated dental implant surfaces on phenotypic expression of human bone-derived cells.J Biomed Mater Res A2004; 71: 98–107.
16.
MuragliaA., CorsiA., RiminucciM.. Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells.J Cell Sci2003; 116: 2949–55.
17.
MartinI., MuragliaA., CampanileG., CanceddaR., QuartoR.. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow.Endocrinology1997; 138: 4456–62.
18.
DozinB., MalpeliM., CamardellaL., CanceddaR., PietrangeloA.. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects.Matrix Biol2002; 21: 449–59.
19.
MalpeliM., RandazzoN., CanceddaR., DozinB.. Serum-free growth medium sustains commitment of human articular chondrocyte through maintenance of Sox9 expression.Tissue Eng2004; 10: 145–55.
20.
MuragliaA., PereraM., VerardoS.. DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cells.Eur J Cell Biol2008; 87: 751–61.
21.
ChenJ.M., AimesR.T., WardG.R., YoungleibG.L., QuigleyJ.P.. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-trans-formed chicken embryo fibroblasts.J Biol Chem1991; 266: 5113–21.
22.
PaganiF., RrancucciC.M., MoroL.. Markers of bone turnover: biochemical and clinical perspectives.J Endocrinol Invest2005; 28: 8–13.
23.
BracciniA., WendtD., JaquieryC.. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts.Stem Cells2005; 23: 1066–72.
24.
PapadimitropoulosA., MastrogiacomoM., PeyrinF.. Kinetics of in vivo bone deposition by bone marrow stromal cells within a resorbable porous calcium phosphate scaffold: an X-ray computed microtomography study.Biotechnol Bioeng2007; 98: 271–81.
25.
ZreiqatH., HowlettC.R.. Titanium substrata composition influences osteoblastic phenotype: In vitro study.J Biomed Mater Res1999; 47: 360–6.
26.
MaromR., ShurI., SolomonR., BenayahuD.. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells.J Cell Physiol2005; 202: 41–8.
27.
CarvalhoR.S., BumannA., SchafferJ.L., GerstenfeldL.C.. Pre-dominant integrin ligands expressed by osteoblasts show preferential regulation in response to both cell adhesion and mechanical perturbation.J Cell Biochem2002; 84: 497–508.
28.
BehonickD.J., XingZ., LieuS., BuckleyJ.M., LotzJ.C., MarcucioR.S., WerbZ., MiclauT., ColnotC.. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration.PLoS ONE2007; 2: e1150.
29.
RocaH., PhimphilaiM., GopalakrishnanR., XiaoG., FranceschiR.T.. Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene.J Biol Chem2005; 280: 30845–55.
30.
LamourV., DetryC., SanchezC., HenrotinY., CastronovoV., BellahceneA.. Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.J Biol Chem2007; 282: 36240–9.
31.
TyeC.E., RattrayK.R., WarnerK.J., GordonJ.A., SodekJ., HunterG.K., GoldbergH.A.. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein.J Biol Chem2003; 278: 7949–55.
CooperL.F., YliheikkilaP.K., FeltonD.A., WhitsonS.W.. Spatiotemporal assessment of fetal bovine osteoblast culture differentiation indicates a role for BSP in promoting differentiation.J Bone Miner Res1998; 13: 620–32.
34.
KayedH., KleeffJ., KelegS.. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.Cancer Lett2007; 245: 171–83.
35.
KaradagA., FisherL.W.. Bone sialoprotein enhances migration of bone marrow stromal cells through matrices by bridging MMP-2 to alpha(v)beta3-integrin.J Bone Miner Res2006; 21: 1627–36.
36.
HilbigH., KirstenM., RupiettaR.. Implant surface coatings with bone sialoprotein, collagen, and fibronectin and their effects on cells derived from human maxillar bone.Eur J Med Res2007; 12: 6–12.
37.
OTooleG.C., SalihE., GallagherC., FitzPatrickD., O'HigginsN., O'RourkeS.K.. Bone sialoprotein-coated femoral implants are osteoinductive but mechanically compromised.J Orthop Res2004; 22: 641–6.
38.
BarriasC.C., RibeiroC.C., LamghariM., MirandaC.S., BarbosaM.A.. Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres.J Biomed Mater Res A2005; 72: 57–66.
39.
ZhangP., HongZ., YuT., ChenX., JingX.. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide).Biomaterials2008; 30: 58–70.
